Skip to main navigation Skip to search Skip to main content

Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer

  • G Sette
  • , Valentina Salvati
  • , M Mottolese
  • , P Visca
  • , E Gallo
  • , K Fecchi
  • , E Pilozzi
  • , E Duranti
  • , E Policicchio
  • , M Tartaglia
  • , M Milella
  • , Ruggero De Maria Marchiano
  • , A. Eramo*
    • *Corresponding author

Research output: Contribution to journal › Article › peer-review

25   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science